Results 51 to 60 of about 148,802 (383)

Peculiarities of рH-Monitoring Indices in Patients with Gastroesophageal Reflux Disease Combined with Oddi’s Sphincter Dysfunction

open access: yesGastroenterologìa, 2015
This article is devoted to the results of the research of comorbid pathologies such as gastroesophageal reflux disease and Oddi’s sphincter dysfunction.
Yu.M. Stepanov   +4 more
doaj   +1 more source

The Role of Pepsinogenes and Some Intestinal Hormones in Pathogenesis of Gastroesophageal Reflux Disease [PDF]

open access: yes, 2018
80 patients with gastroesophageal reflux disease (GERD) were examined. The diagnosis of GERD was based on the history of the disease, complaints of patients, the results of daily monitoring of pH in the lower third of the esophagus, data of ...
Boichuk, V. (Vira)
core   +2 more sources

Hubungan Obesitas dengan Kejadian Gastroesophageal Reflux Disease di RSUP Dr. M. Djamil Padang

open access: yesJurnal Ilmu Kesehatan Indonesia, 2023
Latar Belakang: Gastroesophageal Reflux Disease merupakan kondisi patologis akibat refluks kandungan lambung ke esofagus yang terjadi berulang kali. Kondisi obesitas dapat meningkatkan tekanan intra-abdomen dan menurunkan fungsi esofagus serta Lower ...
Iqbal Muhammad Helmi   +2 more
doaj   +1 more source

Optimal management of severe symptomatic gastroesophageal reflux disease

open access: yesJournal of Internal Medicine, 2020
Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients remain symptomatic despite PPI treatment.
Nicholas J. Talley, M. Z. Irani
semanticscholar   +1 more source

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. [PDF]

open access: yes, 2017
Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial pneumonia of unknown etiology, primarily affects older adults and leads to a progressive decline in lung function and quality of life.
Collard, Harold R, Oldham, Justin M
core   +2 more sources

The features of esophageal daily pH-monitoring depending on the clinical form of gastroesophageal reflux disease in type 2 diabetic patients

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2018
Background. The purpose of the study was to determine the features of esophageal daily pH-monitoring depending on the clinical form of gastroesophageal reflux disease in type 2 diabetic patients. Material and methods.
Yo.I. Pichkar   +3 more
doaj   +1 more source

Prospective study on effect of Helicobacter pylori on gastroesophageal reflux disease [PDF]

open access: yesZanco Journal of Medical Sciences, 2017
Background and objective: The Helicobacter pylori infections role in etiology of peptic ulcer is well known, but its role in gastroesophageal reflux disease is one of the important issues which has to be confirmed.
Sabah Jalal Shareef
doaj   +1 more source

Hiatoplasty with crura buttressing versus hiatoplasty alone during laparoscopic sleeve gastrectomy [PDF]

open access: yes, 2017
Introduction. In obese patients with hiatal hernia (HH), laparoscopic sleeve gastrectomy (LSG) with cruroplasty is an option but use of prosthetic mesh crura reinforcement is debated.
Badiali, Danilo   +6 more
core   +3 more sources

Evolution of gastroesophageal reflux disease symptoms after bariatric surgery: A dose–response meta-analysis

open access: yesSurgery Open Science, 2022
Background: Obesity is associated with increased prevalence of gastroesophageal reflux disease, with recent reports suggesting improvement in gastroesophageal reflux disease symptoms and weight loss following bariatric surgical intervention. However, the
Abdel-Naser Elzouki, MD, MSc, PhD, FRCP, FACP   +9 more
doaj  

Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study [PDF]

open access: yes, 2011
Background and objective: Gastro-oesophageal reflux has been implicated in the pathogenesis of chronic cough. Guidelines on management suggest a therapeutic trial of anti-reflux medication.
Beecher   +41 more
core   +1 more source

Home - About - Disclaimer - Privacy